Product Images Esomeprazole Magnesium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Esomeprazole Magnesium NDC 68788-4014 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Esomeprazole Magnesium D-R Capsules USP 20mg - 20mg 30s
Table-3 - Table 3
Table-4 - Table 4
This information discusses the impact of CYP2C19 or CYP3A4 inducers on esomeprazole exposure, specifically highlighting the decreased exposure of esomeprazole when used concomitantly with strong inducers such as St. John's Wort and rifampin. It also mentions increased exposure of esomeprazole when taken with Voriconazole and advises on dose adjustments for patients with Zollinger-Ellison syndrome who may require higher doses. The text emphasizes the importance of consulting prescribing information for specific drugs such as Ritonavir-containing products.*
esomeprazole-structure - esomeprazole structure
esomeprazole-fig2 - esomeprazole fig2
This text provides information on the percentage of maintenance for different doses of Esomeprazole Magnesium and placebo over a certain period. The doses mentioned are 40mg, 20mg, and 10mg, with the number of participants (N) for each dose also given. The data may refer to a study or trial evaluating the effectiveness of Esomeprazole Magnesium compared to a placebo in maintaining certain characteristics or conditions over a period of time.*
esomeprazole-fig3 - esomeprazole fig3
This text provides information about the percent of individuals who maintained their condition with different doses of Esomeprazole Magnesium (40 mg, 20 mg, 10 mg) and a placebo. Data is presented for each group (N = number of participants).*
esomeprazole-fig4 - esomeprazole fig4
Not available.*
esomeprazole-fig5 - esomeprazole fig5
This text provides information about the percentage of patients who are symptom-free when taking Esomeprazole Magnesium in 20mg or 40mg doses. It references diary days 14, 21, and 28. The specific details or context of the symptom-free percentage are not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
